Article info
PDFPostScript
Letter
Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: a pilot study
- Correspondence to Professor Consuelo Pérez-Rico, Department of Ophthalmology, University Hospital Principe de Asturias, University of Alcalá, Carretera Alcalá-Meco s/n. 28805 Alcalá de Henares, Madrid, Spain; cinta.perezrico{at}gmail.com
Citation
Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: a pilot study
Publication history
- Accepted May 17, 2009
- First published February 5, 2010.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2009, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.